Analyses of the skin molecules in patients with Parkinson's disease.

Analyses of the skin molecules in patients with Parkinson's disease. - Analyses of the skin molecules in patients with Parkinson's disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032982

Enrollment

100

Registered

2018-06-20

Start date

2018-06-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Panelists with sporadic Parkinson's disease (Hoehn & Yahr stage I or II). 2.Japanese male panelists who are 20-89 years old. 3.Panelists who agree to have their typical daily routines.

Exclusion criteria

Exclusion criteria: 1.Panelists who use the drug for the treatment of Parkinson's disease 2.Panelists who have the type I or II diabetes. 3.Panelists who have the malignant tumors or history of them. 4.Panelists who have the skin diseases, such as atopic dermatitis, acne vulgaris, and psoriasis vulgaris. 5.Panelists who have the infectious diseases, such as HIV, HCV, HIV, and syphilis. 6.Panelists who use the antibiotics within 2 weeks before participation in this study. 7.Panelists who use the prescription drugs having any effects to this study. 8.Panelists who use the prescription topical agents on the face

Design outcomes

Primary

Measure	Time frame
The relationship between skin molecules and states of Parkinson's disease.	—

Secondary

Measure	Time frame
The relationship of the molecules between skin and blood.	—

Countries

Japan

Contacts

Public ContactYuya Uehara

Kao Corporation Biological Science Research

uehara.yuuya@kao.com+81-285-68-7461

Outcome results